vs
Side-by-side financial comparison of CXApp Inc. (CXAI) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.
CXApp Inc. is the larger business by last-quarter revenue ($1.0M vs $996.0K, roughly 1.0× PAVmed Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -544.1%, a 7009.9% gap on every dollar of revenue. On growth, PAVmed Inc. posted the faster year-over-year revenue change (25.9% vs -38.5%). CXApp Inc. produced more free cash flow last quarter ($-3.6M vs $-8.9M).
CXApp Inc. is a technology firm specializing in digital workplace experience solutions. It offers cloud-based software tools for employee engagement, office space optimization, visitor management, and hybrid work coordination, serving mid-to-large enterprises across North America, APAC and Europe.
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
CXAI vs PAVM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $996.0K |
| Net Profit | $-5.6M | $64.4M |
| Gross Margin | 86.9% | -38.7% |
| Operating Margin | -576.9% | -1162.4% |
| Net Margin | -544.1% | 6465.8% |
| Revenue YoY | -38.5% | 25.9% |
| Net Profit YoY | -56.7% | 464.4% |
| EPS (diluted) | — | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0M | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $1.9M | $996.0K | ||
| Q2 24 | $1.8M | $979.0K | ||
| Q1 24 | $1.8M | $1.0M |
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $-3.2M | — | ||
| Q2 25 | $-3.1M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-3.5M | — | ||
| Q3 24 | $-5.4M | $64.4M | ||
| Q2 24 | $-5.3M | $-10.8M | ||
| Q1 24 | $-5.2M | $-15.2M |
| Q4 25 | 86.9% | — | ||
| Q3 25 | 89.0% | — | ||
| Q2 25 | 86.0% | — | ||
| Q1 25 | 87.7% | — | ||
| Q4 24 | 86.0% | — | ||
| Q3 24 | 80.4% | -38.7% | ||
| Q2 24 | 80.0% | -70.2% | ||
| Q1 24 | 82.0% | -72.7% |
| Q4 25 | -576.9% | — | ||
| Q3 25 | -343.4% | — | ||
| Q2 25 | -336.1% | — | ||
| Q1 25 | -306.0% | — | ||
| Q4 24 | -169.7% | — | ||
| Q3 24 | -194.3% | -1162.4% | ||
| Q2 24 | -206.7% | -1397.8% | ||
| Q1 24 | -197.3% | -1389.7% |
| Q4 25 | -544.1% | — | ||
| Q3 25 | -283.4% | — | ||
| Q2 25 | -256.7% | — | ||
| Q1 25 | -132.0% | — | ||
| Q4 24 | -213.6% | — | ||
| Q3 24 | -286.5% | 6465.8% | ||
| Q2 24 | -297.6% | -1105.9% | ||
| Q1 24 | -284.4% | -1506.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.44 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | — | $-2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.1M | $765.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $-4.9M |
| Total Assets | $32.4M | $30.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | — | $765.0K | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $14.0M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.3M | — | ||
| Q1 25 | $15.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $13.6M | $-4.9M | ||
| Q2 24 | $16.3M | $-73.9M | ||
| Q1 24 | $20.9M | $-68.8M |
| Q4 25 | $32.4M | — | ||
| Q3 25 | $28.5M | — | ||
| Q2 25 | $29.6M | — | ||
| Q1 25 | $29.3M | — | ||
| Q4 24 | $31.8M | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | $39.4M | ||
| Q1 24 | — | $37.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.6M | $-8.9M |
| Free Cash FlowOCF − Capex | $-3.6M | $-8.9M |
| FCF MarginFCF / Revenue | -355.5% | -892.5% |
| Capex IntensityCapex / Revenue | 0.2% | 0.6% |
| Cash ConversionOCF / Net Profit | — | -0.14× |
| TTM Free Cash FlowTrailing 4 quarters | $-10.4M | $-45.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-979.0K | — | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-2.1M | $-8.9M | ||
| Q2 24 | $-1.9M | $-11.7M | ||
| Q1 24 | $-650.0K | $-13.1M |
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-984.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.1M | $-8.9M | ||
| Q2 24 | $-1.9M | $-11.7M | ||
| Q1 24 | $-668.0K | $-13.2M |
| Q4 25 | -355.5% | — | ||
| Q3 25 | -248.1% | — | ||
| Q2 25 | -247.2% | — | ||
| Q1 25 | -80.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -109.3% | -892.5% | ||
| Q2 24 | -108.6% | -1190.9% | ||
| Q1 24 | -36.7% | -1302.1% |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.5% | 0.3% | ||
| Q1 24 | 1.0% | 4.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
